Pops Richard F (CIK 0001126490)

Latest company ownership

Shares held
1,290,390
Last filed at
Feb 7, 2025
Confidence Score
50.5
2025Q4
Confidence Score History
2016Q4 2025Q4
Shares held
2,869
Last filed at
May 22, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2017Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Feb 6, 2025 Feb 7, 2025 Alkermes plc. CEO Sell 95.0 +110,715 9.39% ✗ $2.5M
May 17, 2024 May 21, 2024 NEUROCRINE BIOSCIENCES INC Director Sell 30.0 -2,100 -6.23% ✓ $297.9K
Mar 13, 2024 Mar 15, 2024 NEUROCRINE BIOSCIENCES INC Director Sell 5.0 -23,200 -44.01% ✓ $3.3M
Mar 8, 2024 Mar 12, 2024 NEUROCRINE BIOSCIENCES INC Director Sell 38.8 -1,800 -2.96% ✓ $252.1K
Feb 20, 2024 Feb 22, 2024 NEUROCRINE BIOSCIENCES INC Director Sell 5.0 -15,000 -33.70% ✓ $2M
Feb 8, 2024 Feb 12, 2024 Alkermes plc. CEO Sell 100.0 +126,794 12.04% ✗ $2.5M
Feb 20, 2023 Feb 22, 2023 Alkermes plc. CEO Sell 87.5 +52,182 1.67% ✗ $1.9M
Jan 3, 2023 Jan 5, 2023 NEUROCRINE BIOSCIENCES INC Director Sell 5.0 -15,000 -33.70% ✓ $1.8M
May 9, 2022 May 11, 2022 NEUROCRINE BIOSCIENCES INC Director Sell 10.0 -15,000 -20.26% ✓ $1.1M
May 5, 2022 May 6, 2022 Alkermes plc. CEO Sell 16.3 -347,257 -10.75% ✗ $9.7M
Feb 21, 2022 Feb 23, 2022 Alkermes plc. CEO Sell 20.0 -14,386 -1.63% ✗ $360.8K
Feb 16, 2022 Feb 17, 2022 Alkermes plc. CEO Sell 32.5 -8,038 -0.94% ✗ $215.3K
Sep 14, 2021 Sep 16, 2021 Alkermes plc. CEO Sell 95.0 +45,415 5.73% ✗ $1.1M
May 18, 2021 May 19, 2021 Alkermes plc. CEO Sell 15.0 -150,000 -15.92% ✓ $3.3M
May 11, 2021 May 12, 2021 Alkermes plc. CEO Sell 15.0 -150,000 -15.92% ✓ $3.3M
May 6, 2021 May 7, 2021 Alkermes plc. CEO Sell 20.0 -100,000 -11.21% ✓ $2.2M
Feb 21, 2021 Feb 23, 2021 Alkermes plc. CEO Sell 20.0 -14,386 -1.78% ✗ $281.7K
Feb 16, 2021 Feb 18, 2021 Alkermes plc. CEO Sell 32.5 -11,943 -0.77% ✗ $237K
May 14, 2020 May 14, 2020 Alkermes plc. CEO Sell 23.8 -75,000 -8.99% ✓ $1.1M
May 7, 2020 May 7, 2020 Alkermes plc. CEO Sell 30.0 -50,000 -6.18% ✓ $731.3K
Apr 2, 2020 Apr 3, 2020 Alkermes plc. CEO Sell 30.0 -50,000 -6.18% ✓ $689.5K
Mar 26, 2020 Mar 26, 2020 Alkermes plc. CEO Sell 23.8 -75,000 -8.99% ✓ $1.1M
Mar 19, 2020 Mar 19, 2020 Alkermes plc. CEO Sell 23.8 -75,000 -8.99% ✓ $1.1M
Mar 1, 2020 Mar 3, 2020 Alkermes plc. CEO Sell 22.5 -7,770 -1.01% ✗ $161.9K
Feb 21, 2020 Feb 24, 2020 Alkermes plc. CEO Sell 20.0 -14,386 -1.88% ✗ $291.2K
Feb 16, 2020 Feb 18, 2020 Alkermes plc. CEO Sell 32.5 -11,958 -0.81% ✗ $212.5K
Nov 14, 2019 Nov 15, 2019 Alkermes plc. CEO Sell 20.0 -100,000 -12.25% ✓ $2M
Nov 7, 2019 Nov 8, 2019 Alkermes plc. CEO Sell 27.5 -100,000 -6.52% ✓ $2M
Sep 19, 2019 Sep 23, 2019 Alkermes plc. CEO Sell 20.0 -100,000 -12.25% ✓ $2.2M
Sep 12, 2019 Sep 13, 2019 Alkermes plc. CEO Sell 20.0 -100,000 -12.25% ✓ $2.3M
Sep 5, 2019 Sep 6, 2019 Alkermes plc. CEO Sell 20.0 -100,000 -12.25% ✓ $2M
May 16, 2019 May 24, 2019 Alkermes plc. CEO Sell 27.5 -110,000 -7.13% ✓ $2.7M
Mar 12, 2019 Mar 14, 2019 Alkermes plc. CEO Sell 32.5 -60,000 -4.02% ✓ $2M
Mar 5, 2019 Mar 7, 2019 Alkermes plc. CEO Sell 27.5 -50,000 -6.52% ✓ $1.7M
Mar 1, 2019 Mar 4, 2019 Alkermes plc. CEO Sell 20.0 -7,770 -1.07% ✗ $267.6K
Feb 26, 2019 Feb 27, 2019 Alkermes plc. CEO Sell 32.5 -3,887 -0.55% ✗ $131.8K
Feb 16, 2019 Feb 19, 2019 Alkermes plc. CEO Sell 30.0 -7,913 -0.56% ✗ $257.5K
Dec 7, 2018 Dec 11, 2018 Alkermes plc. CEO Sell 85.0 +15,276 2.29% ✗ $415.7K
Nov 26, 2018 Nov 27, 2018 NEUROCRINE BIOSCIENCES INC Director Sell 22.5 -4,124 -12.26% ✓ $376.8K
Nov 12, 2018 Nov 13, 2018 NEUROCRINE BIOSCIENCES INC Director Sell 22.5 -4,123 -10.92% ✓ $425.9K
Oct 29, 2018 Oct 30, 2018 NEUROCRINE BIOSCIENCES INC Director Sell 22.5 -5,500 -12.71% ✓ $589.2K
May 22, 2018 May 24, 2018 Alkermes plc. CEO Sell 38.8 -20,000 -2.91% ✓ $909.2K
May 15, 2018 May 17, 2018 Alkermes plc. CEO Sell 27.5 -50,000 -6.98% ✓ $2.3M
May 8, 2018 May 10, 2018 Alkermes plc. CEO Sell 27.5 -50,000 -6.98% ✓ $2.2M
May 1, 2018 May 3, 2018 NEUROCRINE BIOSCIENCES INC Director Sell 22.5 -1,253 -2.81% ✗ $105.7K
May 1, 2018 May 3, 2018 Alkermes plc. CEO Sell 27.5 -50,000 -6.98% ✓ $2.2M
Mar 1, 2018 Mar 5, 2018 Alkermes plc. CEO Sell 20.0 -13,558 -1.01% ✗ $793.6K
Feb 26, 2018 Feb 28, 2018 Alkermes plc. CEO Sell 30.0 -4,445 -0.68% ✗ $258.3K
Feb 17, 2018 Feb 21, 2018 Alkermes plc. CEO Sell 40.0 -2,581 -0.40% ✗ $173.6K
Nov 2, 2017 Nov 3, 2017 Alkermes plc. CEO Sell 27.5 -50,000 -7.27% ✓ $2.4M
May 28, 2017 May 30, 2017 Alkermes plc. CEO Sell 20.0 -6,470 -1.00% ✗ $373.3K
May 24, 2017 May 25, 2017 Alkermes plc. CEO Sell 32.5 -25,000 -3.81% ✓ $1.4M
May 17, 2017 May 19, 2017 Alkermes plc. CEO Sell 27.5 -50,000 -7.35% ✓ $2.9M
May 10, 2017 May 11, 2017 Alkermes plc. CEO Sell 32.5 -25,000 -3.81% ✓ $1.4M
May 3, 2017 May 5, 2017 NEUROCRINE BIOSCIENCES INC Director Sell 22.5 -952 -3.13% ✗ $50.8K
Mar 3, 2017 Mar 6, 2017 Alkermes plc. CEO Sell 30.0 -6,117 -0.96% ✗ $373K
Mar 1, 2017 Mar 2, 2017 Alkermes plc. CEO Sell 20.0 -8,234 -1.30% ✗ $491.7K
Feb 26, 2017 Feb 27, 2017 Alkermes plc. CEO Sell 32.5 -4,705 -0.76% ✗ $249.3K
Nov 29, 2016 Nov 30, 2016 Alkermes plc. CEO Sell 32.5 -30,000 -4.70% ✓ $1.7M
Nov 22, 2016 Nov 22, 2016 Alkermes plc. CEO Sell 32.5 -30,000 -4.70% ✓ $1.8M
Nov 15, 2016 Nov 17, 2016 Alkermes plc. CEO Sell 32.5 -30,000 -4.70% ✓ $1.8M
Nov 8, 2016 Nov 10, 2016 Alkermes plc. CEO Sell 32.5 -30,000 -4.70% ✓ $1.6M
Oct 5, 2016 Oct 7, 2016 Alkermes plc. CEO Sell 20.0 -9,410 -1.52% ✗ $436.9K